Picture of Taisho Pharmaceutical Holdings Co logo

4581 — Taisho Pharmaceutical Holdings Co News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Table: Taisho Pharmaceutical HD - 9-MTH group results

Feb 14 (Reuters)- 
             Taisho Pharmaceutical Holdings Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended       Year to 
                  Dec 31, 2019        Dec 31, 2018     Mar 31, 2020 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales              211.34              199.90           290.50    
                   (+5.7 pct)          (-7.4 pct)       (+11.1 pct) 
  Operating           17.57               28.12            21.50    
                   (-37.5 pct)         (-1.5 pct)       (-31.1 pct) 
  Recurring           20.97               36.16            26.00    
                   (-42.0 pct)         (+8.3 pct)       (-36.4 pct) 
  Net                 17.93               51.40            21.00    
                   (-65.1 pct)         (+94.2 pct)      (-56.8 pct) 
  EPS              224.64 yen          643.93 yen       263.13 yen  
  EPS Diluted      224.38 yen          643.33 yen                   
  Ann Div                              120.00 yen       110.00 yen  
  -Q2 div           50.00 yen           50.00 yen                   
  -Q4 div                               70.00 yen        60.00 yen  
  
  NOTE - Taisho Pharmaceutical Holdings Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4581.T

Recent news on Taisho Pharmaceutical Holdings Co

See all news